AB.PA
AB Science SA
Price:  
1.54 
EUR
Volume:  
389,677.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AB.PA EV/EBITDA

-172.0%
Upside

As of 2026-01-02, the EV/EBITDA ratio of AB Science SA (AB.PA) is -17.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AB.PA's latest enterprise value is 115.62 mil EUR. AB.PA's TTM EBITDA according to its financial statements is -6.73 mil EUR. Dividing these 2 quantities gives us the above AB.PA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.9x - 7.3x 6.8x
Forward P/E multiples 10.6x - 12.0x 10.8x
Fair Price (1.29) - (0.96) (1.11)
Upside -183.7% - -162.2% -172.0%
1.54 EUR
Stock Price
(1.11) EUR
Fair Price

AB.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-12-31 -17.18
2025-12-30 -16.04
2025-12-29 -15.51
2025-12-24 -14.80
2025-12-23 -14.86
2025-12-22 -14.58
2025-12-19 -14.58
2025-12-18 -14.11
2025-12-17 -14.54
2025-12-16 -13.87
2025-12-15 -13.83
2025-12-12 -14.07
2025-12-11 -14.13
2025-12-10 -13.78
2025-12-09 -13.66
2025-12-08 -13.60
2025-12-05 -14.03
2025-12-04 -13.85
2025-12-03 -13.46
2025-12-02 -13.68
2025-12-01 -13.50
2025-11-28 -13.74
2025-11-27 -13.68
2025-11-26 -13.15
2025-11-25 -13.26
2025-11-24 -13.38
2025-11-21 -13.38
2025-11-20 -13.38
2025-11-19 -13.48
2025-11-18 -13.36
2025-11-17 -13.42
2025-11-14 -13.44
2025-11-13 -13.68
2025-11-12 -13.79
2025-11-11 -13.68
2025-11-10 -13.60
2025-11-07 -13.44
2025-11-06 -13.30
2025-11-05 -13.28
2025-11-04 -13.66
2025-11-03 -13.72
2025-10-31 -14.11
2025-10-30 -13.50
2025-10-29 -13.54
2025-10-28 -13.62
2025-10-27 -13.76
2025-10-24 -13.89
2025-10-23 -13.89
2025-10-22 -14.13
2025-10-21 -14.48